{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:59:13Z","timestamp":1793336353052,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"am","delay-in-days":309,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI152078-05"],"award-info":[{"award-number":["R01 AI152078-05"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88881.942500\/2024-01"],"award-info":[{"award-number":["88881.942500\/2024-01"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fungal Biology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.funbio.2025.101544","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T08:09:55Z","timestamp":1737792595000},"page":"101544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["A Cryptococcus neoformans polysaccharide conjugate vaccine made with filtered polysaccharide elicits protective immunity in mice"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4694-3448","authenticated-orcid":false,"given":"Piotr R.","family":"Stempinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Ramos Irizarry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9997-5278","authenticated-orcid":false,"given":"Scott A.","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia C.","family":"Liporagi Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5564-3538","authenticated-orcid":false,"given":"Samuel","family":"Rodrigues Dos Santos J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8581-7831","authenticated-orcid":false,"given":"Maggie P.","family":"Wear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Casadevall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.funbio.2025.101544_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s40475-015-0046-y","article-title":"Cryptococcal meningitis: diagnosis and management update","volume":"2","author":"Abassi","year":"2015","journal-title":"Curr Trop Med Rep"},{"issue":"2","key":"10.1016\/j.funbio.2025.101544_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/cei.13356","article-title":"A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens","volume":"198","author":"Abraham","year":"2019","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.funbio.2025.101544_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/mmy.40.5.479.484","article-title":"Fungemia in a cancer patient caused by fluconazole-resistant Cryptococcus laurentii","volume":"40","author":"Averbuch","year":"2002","journal-title":"Med. Mycol."},{"issue":"5","key":"10.1016\/j.funbio.2025.101544_bib4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tim.2017.10.002","article-title":"A call to arms: quest for a cryptococcal vaccine","volume":"26","author":"Caballero Van Dyke","year":"2018","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.funbio.2025.101544_bib5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3389\/fimmu.2018.00855","article-title":"Mechanisms of Cryptococcus neoformans-mediated host damage","volume":"9","author":"Casadevall","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.funbio.2025.101544_bib6","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1080\/21505594.2018.1431087","article-title":"The capsule of Cryptococcus neoformans","volume":"10","author":"Casadevall","year":"2019","journal-title":"Virulence"},{"issue":"6","key":"10.1016\/j.funbio.2025.101544_bib7","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/infdis\/165.6.1086","article-title":"Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection","volume":"165","author":"Casadevall","year":"1992","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.funbio.2025.101544_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.01021-21","article-title":"Expanding the pathogenic potential concept to incorporate fulminancy, time, and virulence factors","volume":"7","author":"Casadevall","year":"2022","journal-title":"mSphere"},{"issue":"2","key":"10.1016\/j.funbio.2025.101544_bib9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1128\/CDLI.5.2.146-159.1998","article-title":"Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network","volume":"5","author":"Cherniak","year":"1998","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"10","key":"10.1016\/j.funbio.2025.101544_bib10","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.vaccine.2010.12.134","article-title":"Evaluation of Cryptococcus neoformans galactoxylomannan-protein conjugate as vaccine candidate against murine cryptococcosis","volume":"29","author":"Chow","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.funbio.2025.101544_bib11","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1128\/IAI.67.6.3096-3107.1999","article-title":"In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies","volume":"67","author":"Cleare","year":"1999","journal-title":"Infect. Immun."},{"issue":"4","key":"10.1016\/j.funbio.2025.101544_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00483-19","article-title":"Intranasal inoculation of Cryptococcus neoformans in mice produces nasal infection with rapid brain dissemination","volume":"4","author":"Coelho","year":"2019","journal-title":"mSphere"},{"key":"10.1016\/j.funbio.2025.101544_bib13","doi-asserted-by":"crossref","DOI":"10.1021\/acsinfecdis.4c00094","article-title":"Semisynthetic glycoconjugate vaccine candidates against Cryptococcus neoformans","author":"Crawford","year":"2024","journal-title":"ACS Infect. Dis."},{"issue":"4","key":"10.1016\/j.funbio.2025.101544_bib14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1567-1364.2006.00073.x","article-title":"Towards a vaccine for Cryptococcus neoformans: principles and caveats","volume":"6","author":"Datta","year":"2006","journal-title":"FEMS Yeast Res."},{"issue":"10","key":"10.1016\/j.funbio.2025.101544_bib15","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1128\/iai.59.10.3700-3707.1991","article-title":"Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity","volume":"59","author":"Devi","year":"1991","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.funbio.2025.101544_bib16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0264-410X(95)00256-Z","article-title":"Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model","volume":"14","author":"Devi","year":"1996","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.funbio.2025.101544_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228558","article-title":"Rational design of a glycoconjugate vaccine against group A Streptococcus","volume":"21","author":"Di Benedetto","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.funbio.2025.101544_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/iid3.155","article-title":"Complete Freund's adjuvant induces experimental autoimmune myocarditis by enhancing IL-6 production during initiation of the immune response","volume":"5","author":"Fontes","year":"2017","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.funbio.2025.101544_bib19","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/199710a0","article-title":"Immunization against cryptococcus neoformans by capsular polysaccharide","volume":"199","author":"Gadebusch","year":"1963","journal-title":"Nature"},{"key":"10.1016\/j.funbio.2025.101544_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.117859","article-title":"Simultaneous purification and depolymerization of Streptococcus pneumoniae serotype 2 capsular polysaccharides by trifluoroacetic acid","volume":"261","author":"Gaikwad","year":"2021","journal-title":"Carbohydr. Polym."},{"issue":"7","key":"10.1016\/j.funbio.2025.101544_bib21","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1021\/bc800153t","article-title":"Improved procedure for direct coupling of carbohydrates to proteins via reductive amination","volume":"19","author":"Gildersleeve","year":"2008","journal-title":"Bioconjugate Chem."},{"issue":"5","key":"10.1016\/j.funbio.2025.101544_bib22","doi-asserted-by":"crossref","first-page":"901","DOI":"10.4049\/jimmunol.98.5.901","article-title":"Protein conjugates of polysaccharide from Cryptococcus neoforman s","volume":"98","author":"Goren","year":"1967","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.funbio.2025.101544_bib56","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.4049\/jimmunol.2100386","article-title":"Murine inducible nitric oxide synthase expression is essential for antifungal defenses in kidneys during disseminated cryptococcus deneoformans infection","volume":"207","author":"Goughenour","year":"2021","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.funbio.2025.101544_bib23","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41579-021-00511-0","article-title":"Treatment strategies for cryptococcal infection: challenges, advances and future outlook","volume":"19","author":"Iyer","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.funbio.2025.101544_bib24","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1128\/IAI.73.1.592-598.2005","article-title":"Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans","volume":"73","author":"Kelly","year":"2005","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.funbio.2025.101544_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02055969","article-title":"Induction of humoral antibody response by soluble polysaccharide of Cryptococcus neoformans","volume":"54","author":"Kozel","year":"1974","journal-title":"Mycopathol. Mycol. Appl."},{"issue":"3","key":"10.1016\/j.funbio.2025.101544_bib26","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1128\/iai.18.3.701-707.1977","article-title":"Immune response to Cryptococcus neoformans soluble polysaccharide: immunological unresponsiveness","volume":"18","author":"Kozel","year":"1977","journal-title":"Infect. Immun."},{"issue":"10","key":"10.1016\/j.funbio.2025.101544_bib27","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1128\/JCM.36.10.2817-2822.1998","article-title":"Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies","volume":"36","author":"Lozano-Chiu","year":"1998","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.funbio.2025.101544_bib28","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1128\/IAI.72.3.1746-1754.2004","article-title":"Protective efficacy of antigenic fractions in mouse models of cryptococcosis","volume":"72","author":"Mansour","year":"2004","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.funbio.2025.101544_bib29","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1128\/IAI.74.3.1500-1504.2006","article-title":"Estimating the relative contributions of virulence factors for pathogenic microbes","volume":"74","author":"McClelland","year":"2006","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.funbio.2025.101544_bib30","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1128\/EC.00162-07","article-title":"Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans","volume":"6","author":"McFadden","year":"2007","journal-title":"Eukaryot. Cell"},{"issue":"12","key":"10.1016\/j.funbio.2025.101544_bib31","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/cid\/ciw151","article-title":"Cryptococcal meningitis treatment strategies affected by the explosive cost of flucytosine in the United States: a cost-effectiveness analysis","volume":"62","author":"Merry","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.funbio.2025.101544_bib32","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180238","article-title":"Structural and immunological characterization of E. coli derived recombinant CRM197 protein used as carrier in conjugate vaccines","volume":"38","author":"Mishra","year":"2018","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.funbio.2025.101544_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1086\/426511","article-title":"Glucuronoxylomannan, a microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophages","volume":"191","author":"Monari","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"16","key":"10.1016\/j.funbio.2025.101544_bib34","doi-asserted-by":"crossref","first-page":"8841","DOI":"10.1073\/pnas.97.16.8841","article-title":"Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens","volume":"97","author":"Nathan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.funbio.2025.101544_bib35","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1128\/IAI.70.6.2812-2819.2002","article-title":"Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificity","volume":"70","author":"Netski","year":"2002","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.funbio.2025.101544_bib36","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1128\/EC.00122-07","article-title":"Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations","volume":"6","author":"Nimrichter","year":"2007","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.funbio.2025.101544_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.739027","article-title":"Cryptococcus neoformans \u0394sgl1 vaccination requires either CD4+ or CD8+ T cells for complete host protection","volume":"11","author":"Normile","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"3","key":"10.1016\/j.funbio.2025.101544_bib38","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1128\/CMR.00001-12","article-title":"The Cryptococcus neoformans capsule: a sword and a shield","volume":"25","author":"O'Meara","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"issue":"5","key":"10.1016\/j.funbio.2025.101544_bib39","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/pro.108","article-title":"Trichloroacetic acid-induced protein precipitation involves the reversible association of a stable partially structured intermediate","volume":"18","author":"Rajalingam","year":"2009","journal-title":"Protein Sci."},{"issue":"10","key":"10.1016\/j.funbio.2025.101544_bib40","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1128\/IAI.69.10.6064-6073.2001","article-title":"Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans","volume":"69","author":"Retini","year":"2001","journal-title":"Infect. Immun."},{"issue":"7","key":"10.1016\/j.funbio.2025.101544_bib55","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.4049\/jimmunol.168.7.3419","article-title":"Antibody efficacy in murine pulmonary cryptococcus neoformans infection: a role for nitric oxide","volume":"168","author":"Rivera","year":"2002","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.funbio.2025.101544_bib41","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1286-4579(99)80025-2","article-title":"Pathogenicity of Cryptococcus neoformans: virulence factors and immunological mechanisms","volume":"1","author":"Rodrigues","year":"1999","journal-title":"Microb. Infect."},{"key":"10.1016\/j.funbio.2025.101544_bib42","volume":"vol. 114","author":"Santos-Gandelman","year":"2019"},{"issue":"27","key":"10.1016\/j.funbio.2025.101544_bib43","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1016\/j.vaccine.2010.04.072","article-title":"Overview of the development and current use of CRM(197) conjugate vaccines for pediatric use","volume":"28","author":"Shinefield","year":"2010","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.funbio.2025.101544_bib44","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1128\/IAI.00661-06","article-title":"Role of capsule and interleukin-6 in long-term immune control of Cryptococcus neoformans infection by specifically activated human peripheral blood mononuclear cells","volume":"74","author":"Siddiqui","year":"2006","journal-title":"Infect. Immun."},{"issue":"7","key":"10.1016\/j.funbio.2025.101544_bib45","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1128\/AAC.00295-09","article-title":"Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence","volume":"53","author":"Sionov","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.funbio.2025.101544_bib46","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01746-24","article-title":"Immunological correlates of protection mediated by a whole organism, Cryptococcus neoformans, vaccine deficient in chitosan","volume":"15","author":"Specht","year":"2024","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.funbio.2025.101544_bib47","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1074-7613(02)00328-X","article-title":"CR3 (CD11b\/CD18) and CR4 (CD11c\/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans","volume":"16","author":"Taborda","year":"2002","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.funbio.2025.101544_bib48","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00547-16","article-title":"Induction of protective immunity to cryptococcal infection in mice by a heat-killed, chitosan-deficient strain of Cryptococcus neoformans","volume":"7","author":"Upadhya","year":"2016","journal-title":"mBio"},{"issue":"8","key":"10.1016\/j.funbio.2025.101544_bib49","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1128\/iai.63.8.2919-2923.1995","article-title":"Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes","volume":"63","author":"Vecchiarelli","year":"1995","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.funbio.2025.101544_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02145-19","article-title":"A heat-killed Cryptococcus mutant strain induces host protection against multiple invasive mycoses in a murine vaccine model","volume":"10","author":"Wang","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.funbio.2025.101544_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119547","article-title":"Lyophilization induces physicochemical alterations in cryptococcal exopolysaccharide","volume":"291","author":"Wear","year":"2022","journal-title":"Carbohydr. Polym."},{"issue":"3","key":"10.1016\/j.funbio.2025.101544_bib52","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/IAI.00274-06","article-title":"Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain","volume":"75","author":"Wormley","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.funbio.2025.101544_bib53","article-title":"Macrophage-mediated inflammatory response decreases mycobacterial survival in mouse MSCs by augmenting NO production","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.funbio.2025.101544_bib54","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ab.2004.09.042","article-title":"Carbohydrate composition analysis of bacterial polysaccharides: optimized acid hydrolysis conditions for HPAEC-PAD analysis","volume":"201","author":"Yu","year":"1992","journal-title":"Anal. Biochem."}],"container-title":["Fungal Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878614625000108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878614625000108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T23:59:15Z","timestamp":1740700755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878614625000108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1878614625000108"],"URL":"https:\/\/doi.org\/10.1016\/j.funbio.2025.101544","relation":{},"ISSN":["1878-6146"],"issn-type":[{"value":"1878-6146","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Cryptococcus neoformans polysaccharide conjugate vaccine made with filtered polysaccharide elicits protective immunity in mice","name":"articletitle","label":"Article Title"},{"value":"Fungal Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.funbio.2025.101544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 British Mycological Society. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101544"}}